Next-generation Performance Enhancing Technologies for Sexual Wellbeing

A multinational consumer goods company is seeking novel technologies and ingredients to enhance sexual wellness, spanning both medicated and non-medicated approaches. Specifically, the team is interested in technologies that can be used within the sexual wellness space to enhance arousal, allow people to feel confident and in-control during sex, allowing sex to last longer and to ensure all parties are satisfied after sex. They are interested in engaging with experts in both the pharmaceutical and cosmetic space. 

Approaches of Interest: 

• Ingredients and sensorials acting on mechanical, chemical, or thermal receptors in the genital area, including vasodilators, numbing agents, and pleasure-enhancing sensates 
• Solutions for low libido, erectile dysfunction, and premature ejaculation that surpass current industry standards and address unmet consumer needs 
• Technologies that could enhance the experience of using condoms, personal lubricants, or pleasure gels
• Approaches to improve key attributes of intimate wellness products, including being faster acting, longer acting, and allowing more control

Out of Scope: 

• Supplements and approaches that require daily administration 
• Devices unless they offer a novel approach 

Developmental Stages of Interest: 

• Opportunities with proof of efficacy are of interest, with solutions closer to market being preferred 
• Approaches should have proof of principle in an in vitro or animal model or technical testing 

Submission Information 

Submission of one-page, 200–300-word briefs is encouraged, along with any optional supplementary information e.g. relevant publications. This campaign is open to submissions from academia, SMEs, and start-up companies. In submitting to this campaign, you confirm that your submission contains only non-confidential information. 

Opportunity for Collaboration 

Our client is a large multinational company with resources to develop a product and take it to market. They are open to a range of collaboration opportunities, with the most appropriate outcome being decided on a case-by-case basis. Example outcomes include licensing assets, project/PhD funding, and research collaborations.